Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 10951-11000 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05008783
A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma
PHASE3
Active, not recruiting
610 participants
Started: Sep 17, 2021 · Completed: Oct 18, 2025
2 conditions
1 sponsor
7 locations
NCT06314659
Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months
PHASE3
Active, not recruiting
630 participants
Started: Sep 17, 2021 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT03678350
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
PHASE1
Active, not recruiting
9 participants
Started: Sep 17, 2021 · Completed: Oct 13, 2026
3 conditions
2 sponsors
1 location
NCT04980404
Inqovi Maintenance Therapy in Myeloid Neoplasms
PHASE1
Active, not recruiting
22 participants
Started: Sep 17, 2021 · Completed: Nov 30, 2026
3 conditions
2 sponsors
1 location
NCT04815278
NC Works4Health: Reducing Chronic Disease Risks in Socioeconomically Disadvantaged, Unemployed Populations
NA
Active, not recruiting
600 participants
Started: Sep 17, 2021 · Completed: Nov 30, 2025
3 conditions
2 sponsors
1 location
NCT05004857
The Effect of Reading Therapy on Newborns
NA
Active, not recruiting
1 participants
Started: Sep 17, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05002998
TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study
PHASE4
Active, not recruiting
313 participants
Started: Sep 16, 2021 · Completed: Jan 5, 2026
1 condition
1 sponsor
29 locations
NCT05008211
Information-Motivation-Behavioral Skills Model-based Intervention to Domiciliary Non-invasive Ventilation of Patients
NA
Active, not recruiting
124 participants
Started: Sep 16, 2021 · Completed: Aug 15, 2025
2 conditions
3 sponsors
1 location
NCT05035394
Swedish Microinvasive Glaucoma Surgery Study (SMIGS)
NA
Active, not recruiting
120 participants
Started: Sep 16, 2021 · Completed: Sep 30, 2027
6 conditions
1 sponsor
1 location
NCT05006794
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
PHASE1
Active, not recruiting
145 participants
Started: Sep 15, 2021 · Completed: Mar 31, 2029
1 condition
1 sponsor
13 locations
NCT04704544
Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)
NA
Active, not recruiting
652 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2025
1 condition
4 sponsors
1 location
NCT04909801
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
PHASE3
Active, not recruiting
338 participants
Started: Sep 15, 2021 · Completed: Sep 1, 2027
1 condition
1 sponsor
75 locations
NCT04776252
Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)
PHASE3
Active, not recruiting
2,000 participants
Started: Sep 15, 2021 · Completed: May 17, 2028
1 condition
1 sponsor
93 locations
NCT05111834
IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms
NA
Active, not recruiting
112 participants
Started: Sep 15, 2021 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05058976
Romosozumab Use to Build Skeletal Integrity
PHASE4
Active, not recruiting
184 participants
Started: Sep 15, 2021 · Completed: Sep 30, 2027
3 conditions
3 sponsors
1 location
NCT04877821
The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC
PHASE2
Active, not recruiting
31 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04838769
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NA
Active, not recruiting
154 participants
Started: Sep 15, 2021 · Completed: Mar 31, 2027
1 condition
1 sponsor
21 locations
NCT03923907
Complex Exercise Intervention to Normalize Blood Pressure and Nocturnal Dipping in Patients With Hypertension
NA
Active, not recruiting
198 participants
Started: Sep 15, 2021 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT04832477
Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US
NA
Active, not recruiting
500 participants
Started: Sep 15, 2021 · Completed: Feb 4, 2026
4 conditions
1 sponsor
1 location
NCT05082090
A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices
N/A
Active, not recruiting
2,000 participants
Started: Sep 15, 2021 · Completed: Dec 31, 2031
1 condition
1 sponsor
20 locations
NCT05063786
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
PHASE3
Active, not recruiting
27 participants
Started: Sep 14, 2021 · Completed: Jun 30, 2026
1 condition
4 sponsors
106 locations
NCT04944576
Observational Study to Evaluate Safety and Performance of the Total Ankle Prosthesis, EasyMove®
N/A
Active, not recruiting
82 participants
Started: Sep 14, 2021 · Completed: Sep 13, 2029
1 condition
1 sponsor
6 locations
NCT05785910
Adaptation of the Uniform Data Set for Telematic Administration
NA
Active, not recruiting
14 participants
Started: Sep 14, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05025358
A Study of LP-118 in Patients With Advanced Tumors
PHASE1
Active, not recruiting
96 participants
Started: Sep 14, 2021 · Completed: Dec 30, 2025
2 conditions
1 sponsor
4 locations
NCT04156945
Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men
NA
Active, not recruiting
258 participants
Started: Sep 14, 2021 · Completed: Feb 28, 2026
1 condition
6 sponsors
15 locations
NCT05744895
MAKO Total Knee Artroplasty
N/A
Active, not recruiting
95 participants
Started: Sep 14, 2021 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT04991935
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
PHASE3
Active, not recruiting
368 participants
Started: Sep 14, 2021 · Completed: Sep 29, 2026
1 condition
1 sponsor
167 locations
NCT04994132
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
PHASE3
Active, not recruiting
118 participants
Started: Sep 14, 2021 · Completed: Sep 30, 2027
8 conditions
2 sponsors
251 locations
NCT05010629
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
PHASE2
Active, not recruiting
35 participants
Started: Sep 14, 2021 · Completed: Apr 12, 2027
4 conditions
2 sponsors
2 locations
NCT05193981
A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD
N/A
Active, not recruiting
80 participants
Started: Sep 14, 2021 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT04090723
Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum
NA
Active, not recruiting
12 participants
Started: Sep 14, 2021 · Completed: Nov 1, 2026
3 conditions
2 sponsors
1 location
NCT04966091
Working IVF Patients' Quality of Life
N/A
Active, not recruiting
200 participants
Started: Sep 13, 2021 · Completed: Mar 8, 2025
2 conditions
1 sponsor
1 location
NCT04977986
Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome
PHASE3
Active, not recruiting
215 participants
Started: Sep 13, 2021 · Completed: May 31, 2025
1 condition
1 sponsor
27 locations
NCT05015816
MoleGazer Development Feasibility Study
NA
Active, not recruiting
374 participants
Started: Sep 13, 2021 · Completed: Feb 28, 2026
2 conditions
2 sponsors
1 location
NCT05016245
MANDARIN (S6371)
PHASE3
Active, not recruiting
92 participants
Started: Sep 13, 2021 · Completed: Oct 30, 2026
1 condition
1 sponsor
1 location
NCT04847739
Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)
PHASE2
Active, not recruiting
60 participants
Started: Sep 13, 2021 · Completed: Aug 31, 2026
2 conditions
2 sponsors
15 locations
NCT04712864
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
PHASE1
Active, not recruiting
50 participants
Started: Sep 13, 2021 · Completed: Dec 31, 2025
5 conditions
1 sponsor
4 locations
NCT05021562
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
N/A
Active, not recruiting
354 participants
Started: Sep 13, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05047068
OCS Heart Perfusion Post-Approval Registry
N/A
Active, not recruiting
350 participants
Started: Sep 13, 2021 · Completed: Dec 31, 2029
1 condition
1 sponsor
27 locations
NCT04991480
A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1
Active, not recruiting
390 participants
Started: Sep 13, 2021 · Completed: Mar 31, 2026
3 conditions
1 sponsor
8 locations
NCT04704336
Integration of Hypertension Management Into HIV Care in Nigeria
NA
Active, not recruiting
830 participants
Started: Sep 13, 2021 · Completed: Jan 31, 2026
2 conditions
2 sponsors
2 locations
NCT05052294
COVID-19 Antibody Responses in Cystic Fibrosis
N/A
Active, not recruiting
50 participants
Started: Sep 13, 2021 · Completed: Jun 1, 2025
1 condition
2 sponsors
2 locations
NCT06734962
Evaluation of Bone Regeneration After Apical Surgery Using Advanced Platelet-rich Fibrin: Utilization of Ultrasound for the Assessment of Periapical Lesions
PHASE2
Active, not recruiting
44 participants
Started: Sep 12, 2021 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05068869
Digital Outpatient Services
NA
Active, not recruiting
180 participants
Started: Sep 12, 2021 · Completed: Dec 31, 2024
4 conditions
2 sponsors
2 locations
NCT04765059
A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)
PHASE3
Active, not recruiting
98 participants
Started: Sep 12, 2021 · Completed: Jun 2, 2026
1 condition
2 sponsors
40 locations
NCT04891575
Heart of the Family: A Cardiovascular Disease and Type 2 Diabetes Risk Reduction Intervention in High-Risk Rural Families
NA
Active, not recruiting
540 participants
Started: Sep 11, 2021 · Completed: Feb 11, 2026
2 conditions
2 sponsors
1 location
NCT04911621
Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma
PHASE1/PHASE2
Active, not recruiting
10 participants
Started: Sep 10, 2021 · Completed: Jun 1, 2027
2 conditions
4 sponsors
1 location
NCT04782687
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
PHASE2
Active, not recruiting
73 participants
Started: Sep 10, 2021 · Completed: May 31, 2026
7 conditions
2 sponsors
10 locations
NCT05299931
An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study
PHASE3
Active, not recruiting
108 participants
Started: Sep 10, 2021 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT04895761
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer
PHASE1
Active, not recruiting
6 participants
Started: Sep 10, 2021 · Completed: Sep 1, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
217
218
219
220
221
222
223
More pages
431
Next